Patient considerations and drug selection in the treatment of idiopathic pulmonary fibrosis
Maria A Trawinska,1 Ruwani D Rupesinghe,1 Simon P Hart1,2 1Hull and East Yorkshire Hospitals NHS Trust, 2Hull York Medical School, Academic Respiratory Medicine, Castle Hill Hospital, Cottingham, East Yorkshire, UK Abstract: Idiopathic pulmonary fibrosis (IPF) is a progressive interstitia...
Main Authors: | Trawinska MA, Rupesinghe RD, Hart SP |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-04-01
|
Series: | Therapeutics and Clinical Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/patient-considerations-and-drug-selection-in-the-treatment-of-idiopath-peer-reviewed-article-TCRM |
Similar Items
-
Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges
by: Spagnolo Paolo, et al.
Published: (2012-11-01) -
Erythropoietin: role in idiopathic pulmonary fibrosis revisited
by: Contributors A.O Abdel-Aziz, et al.
Published: (2020-01-01) -
Lung Transplantation in Idiopathic Pulmonary Fibrosis
by: Rosalía Laporta Hernandez, et al.
Published: (2018-08-01) -
Clinical course and management of idiopathic pulmonary fibrosis
by: Caitlin Quinn, et al.
Published: (2019-12-01) -
Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management
by: Justin M. Oldham, et al.
Published: (2017-08-01)